Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Allergan's patent for latisse expired?Mobic injection patent oehringer ingelheim france?Pramlintide approval date?Guselkumab patent expiration?Can i take anti histamine with statin?
See the DrugPatentWatch profile for Omidria
Omidria is a medication used to help prevent and treat eye problems during cataract surgery. It’s administered during the procedure to support better postoperative outcomes for patients undergoing cataract removal with intraocular lens implantation [1].
Omidria is used in the operating room as part of the surgical process for cataract procedures. It is delivered during surgery rather than being taken as a long-term medicine afterward [1].
The medicine is intended to reduce postoperative issues related to inflammation and other complications that can occur after cataract surgery [1].
Omidria is used for patients undergoing cataract surgery with intraocular lens placement, where the surgeon plans to use it intraoperatively to reduce the risk of certain postoperative complications [1].
As with any medication used in the eye during surgery, potential adverse effects can include local eye reactions. The specific risks depend on the product labeling and the patient’s situation, so clinicians follow the approved prescribing information [1].
You can access the official prescribing information for Omidria through the product’s FDA label page [1].
Other Questions About Omidria :